Enanta Pharmaceuticals Inc. sell StockNews.com
Start price
06.04.24
/
50%
€15.20
Target price
06.04.25
-
Performance (%)
-26.97%
Price
22.08.24
€11.00
Summary
This prediction is currently active. The prediction for Enanta Pharmaceuticals Inc. shows a convincing performance of -26.97%. This prediction currently runs until 06.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Enanta Pharmaceuticals Inc. | 2.804% | 2.804% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by StockNews_com for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by StockNews_com for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.70
30.09.23
30.09.23
-
30.09.24
30.09.24
3.74%
22.08.24
22.08.24
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.00
02.09.23
02.09.23
-
02.09.24
02.09.24
-15.38%
22.08.24
22.08.24